Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study
Weiwei Zhu,1,2,* Zhanchou Zhang,1,* Jingfeng Qi,1 Fang Liu,3 Jindong Chen,1,4,5 Jingping Zhao,1,4,5 Xiaofeng Guo1,4,5 1Institute of Mental Health, Second Xiangya Hospital, Central South University, 2Brain Hospital of Hunan Province, Changsha, 3First Affiliated Hospital of Kunming Medical Universi...
Main Authors: | Zhu W, Zhang Z, Qi J, Liu F, Chen J, Zhao J, Guo X |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-07-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/adjunctive-treatment-for-cognitive-impairment-in-patients-with-chronic-a17585 |
Similar Items
-
Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
by: Zhuo K, et al.
Published: (2019-05-01) -
Adjunctive Treatment with Rhodiola Crenulata in Patients with Chronic Obstructive Pulmonary Disease--A Randomized Placebo Controlled Double Blind Clinical Trial.
by: Ming-Lung Chuang, et al.
Published: (2015-01-01) -
5-HT3 antagonist for cognition improvement in schizophrenia: a double blind, placebo-controlled trial
by: Neyousha Mohammadi, et al.
Published: (2010-01-01) -
5-HT3 antagonist for cognition improvement in schizophrenia: a double blind, placebo-controlled trial
by: Neyousha Mohammadi, et al.
Published: (2010-01-01) -
Acetaminophen as Adjuvant to Risperidone in Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
by: Somaye Arabzadeh, et al.
Published: (2018-02-01)